Patent
-
Motion Granted to Amend Joint Claim Construction and Prehearing StatementOctober 30, 2024 | Gibbons
In Fennec v. Cipla, the United States District Court for the District of New Jersey recently granted...
-
Generative AI in USPTO Practice: Key Considerations Under the USPTO’s New Guidance
May 21, 2024 | Gibbons
Generative Artificial Intelligence (AI) tools such as OpenAI’s ChatGPT, Anthropic’s Claude, Midj...
-
Edwards Lifesciences Corp. v. Meril Life Sciences Pvt. Ltd.: Should “Intent” Be Reconsidered in 271(e)(1)?
April 9, 2024 | Customs
Edwards Lifesciences Corp. v. Meril Life Sciences Pvt. Ltd., Appeal No. 22-1877 (Fed. Cir. March 25,...
-
Baxalta Inc. v. Genentech, Inc.: The Federal Circuit Addresses Enablement After Amgen v. Sanofi
September 28, 2023 | Biotech
Baxalta Inc., v. Genentech, Inc., Appeal No. 2022-1461 (Fed. Cir. Sept. 20, 2023) is another in the...
-
District of New Jersey Grants Motion to Dismiss Inequitable Conduct Counterclaim and Strike Affirmative Defenses
May 19, 2023 | Gibbons
In 2109971 Ontario Inc. d/b/a Xcella Furniture v. Best Deals Discount Furniture LLC, the United Stat...
-
District of New Jersey Citing Litigation Tactics Orders Related Hatch-Waxman Cases to Be Tried Together
May 17, 2023 | Gibbons
In Corcept Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc., the United States District Court fo...
-
Southern District of California Strikes Defendant’s Invalidity Theories and References for Failing to Comply With District’s Patent Local Rules
May 16, 2023 | Gibbons
In Taction Technology, Inc. v. Apple Inc., the United States District Court for the Southern Distric...
-
Southern District of Florida Dismisses Patent Infringement Claims for Generalized Allegations and Declaratory Judgment Claims for Lack of Sufficient Immediacy
January 17, 2023 | Gibbons
In Scilex Pharmaceuticals Inc. v. Aveva Drug Delivery Systems, Inc., Apotex Corp., and Apotex Inc., ...
